<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Lee S</submitter><funding>Cure Alzheimer's Fund</funding><funding>NIMH NIH HHS</funding><funding>Cure Alzheimer&amp;apos;s Fund</funding><funding>National Institutes of Health</funding><funding>NIH HHS</funding><pagination>3397-3405</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11095441</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>20(5)</volume><pubmed_abstract>&lt;h4>Introduction&lt;/h4>Genome-wide association studies have identified numerous disease susceptibility loci (DSLs) for Alzheimer's disease (AD). However, only a limited number of studies have investigated the dependence of the genetic effect size of established DSLs on genetic ancestry.&lt;h4>Methods&lt;/h4>We utilized the whole genome sequencing data from the Alzheimer's Disease Sequencing Project (ADSP) including 35,569 participants. A total of 25,459 subjects in four distinct populations (African ancestry, non-Hispanic White, admixed Hispanic, and Asian) were analyzed.&lt;h4>Results&lt;/h4>We found that nine DSLs showed significant heterogeneity across populations. Single nucleotide polymorphism (SNP) rs2075650 in translocase of outer mitochondrial membrane 40 (TOMM40) showed the largest heterogeneity (Cochran's Q = 0.00, I&lt;sup>2&lt;/sup> = 90.08), followed by other SNPs in apolipoprotein C1 (APOC1) and apolipoprotein E (APOE). Two additional loci, signal-induced proliferation-associated 1 like 2 (SIPA1L2) and solute carrier 24 member 4 (SLC24A4), showed significant heterogeneity across populations.&lt;h4>Discussion&lt;/h4>We observed substantial heterogeneity for the APOE-harboring 19q13.32 region with TOMM40/APOE/APOC1 genes. The largest risk effect was seen among African Americans, while Asians showed a surprisingly small risk effect.</pubmed_abstract><journal>Alzheimer's &amp; dementia : the journal of the Alzheimer's Association</journal><pubmed_title>On the effect heterogeneity of established disease susceptibility loci for Alzheimer's disease across different genetic ancestries.</pubmed_title><pmcid>PMC11095441</pmcid><funding_grant_id>R01MH129337</funding_grant_id><funding_grant_id>R01 MH129337</funding_grant_id><pubmed_authors>Alzheimer's Disease Neuroimaging Initiative (ADNI)</pubmed_authors><pubmed_authors>Lutz SM</pubmed_authors><pubmed_authors>Lee S</pubmed_authors><pubmed_authors>Hecker J</pubmed_authors><pubmed_authors>Hahn G</pubmed_authors><pubmed_authors>Prokopenko D</pubmed_authors><pubmed_authors>Lange C</pubmed_authors><pubmed_authors>Tanzi RE</pubmed_authors><pubmed_authors>Mullin K</pubmed_authors></additional><is_claimable>false</is_claimable><name>On the effect heterogeneity of established disease susceptibility loci for Alzheimer's disease across different genetic ancestries.</name><description>&lt;h4>Introduction&lt;/h4>Genome-wide association studies have identified numerous disease susceptibility loci (DSLs) for Alzheimer's disease (AD). However, only a limited number of studies have investigated the dependence of the genetic effect size of established DSLs on genetic ancestry.&lt;h4>Methods&lt;/h4>We utilized the whole genome sequencing data from the Alzheimer's Disease Sequencing Project (ADSP) including 35,569 participants. A total of 25,459 subjects in four distinct populations (African ancestry, non-Hispanic White, admixed Hispanic, and Asian) were analyzed.&lt;h4>Results&lt;/h4>We found that nine DSLs showed significant heterogeneity across populations. Single nucleotide polymorphism (SNP) rs2075650 in translocase of outer mitochondrial membrane 40 (TOMM40) showed the largest heterogeneity (Cochran's Q = 0.00, I&lt;sup>2&lt;/sup> = 90.08), followed by other SNPs in apolipoprotein C1 (APOC1) and apolipoprotein E (APOE). Two additional loci, signal-induced proliferation-associated 1 like 2 (SIPA1L2) and solute carrier 24 member 4 (SLC24A4), showed significant heterogeneity across populations.&lt;h4>Discussion&lt;/h4>We observed substantial heterogeneity for the APOE-harboring 19q13.32 region with TOMM40/APOE/APOC1 genes. The largest risk effect was seen among African Americans, while Asians showed a surprisingly small risk effect.</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 May</publication><modification>2026-06-03T03:58:38.165Z</modification><creation>2026-04-24T03:09:48.241Z</creation></dates><accession>S-EPMC11095441</accession><cross_references><pubmed>38563508</pubmed><doi>10.1002/alz.13796</doi></cross_references></HashMap>